Literature DB >> 23188623

Potential Roles for Infectious Agents in the Pathophysiology of Primary Biliary Cirrhosis: What's New?

Daniel S Smyk1, Eirini I Rigopoulou, Dimitrios P Bogdanos.   

Abstract

Primary biliary cirrhosis (PBC) is a progressive cholestatic liver disease serologically characterized by the presence of high-titer antimitochondrial antibodies and, histologically by chronic nonsuppurative cholangitis and granulomata. The aetiology of the disease remains elusive, although genetic, epigenetic, environmental, and infectious factors have been considered important for the induction of the disease in genetically prone individuals. The disease shows a striking female predominance and becomes clinically overt at the fourth to sixth decade. These characteristics have prompted investigators to consider infections that predominate in women at these ages as the likely candidates for triggering the disease. Recurrent urinary tract infections due to Escherichia coli were the first infections to be considered pathogenetically relevant. Over the years, several other microorganisms have been linked to the pathogenesis of PBC owing to epidemiological, immunological, microbiological, or experimental findings in animal models. Recent studies have provided data supporting the pathogenic role of Novosphingobium aromaticivorans and betaretroviruses. Several reports have linked other organisms to the induction of the disease and/or the maintenance of the auto-aggressive responses that are perpetuated over the course of the disease. This review highlights the findings of the most recent studies investigating the link between infections and PBC. We also discuss the close interplay of the infectious agents with other environmental and genetic factors, which may explain the multifaceted nature of this puzzling disease.

Entities:  

Year:  2013        PMID: 23188623     DOI: 10.1007/s11908-012-0304-2

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  98 in total

Review 1.  Antimitochondrial and other autoantibodies.

Authors:  Dimitrios-Petrou Bogdanos; Harold Baum; Diego Vergani
Journal:  Clin Liver Dis       Date:  2003-11       Impact factor: 6.126

Review 2.  Disease-specific autoantibodies in primary biliary cirrhosis.

Authors:  Dimitrios P Bogdanos; Lars Komorowski
Journal:  Clin Chim Acta       Date:  2010-12-23       Impact factor: 3.786

3.  Natural history of early primary biliary cirrhosis.

Authors:  J V Metcalf; H C Mitchison; J M Palmer; D E Jones; M F Bassendine; O F James
Journal:  Lancet       Date:  1996-11-23       Impact factor: 79.321

4.  Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations.

Authors:  M I Prince; S J Ducker; O F W James
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

5.  Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.

Authors:  E J Heathcote
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

6.  Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.

Authors:  Maria G Mytilinaiou; Wolfgang Meyer; Thomas Scheper; Eirini I Rigopoulou; Christian Probst; Andreas L Koutsoumpas; Daniel Abeles; Andrew K Burroughs; Lars Komorowski; Diego Vergani; Dimitrios P Bogdanos
Journal:  Clin Chim Acta       Date:  2012-04-03       Impact factor: 3.786

Review 7.  Autoimmunity and environment: am I at risk?

Authors:  Daniel Smyk; Eirini I Rigopoulou; Harold Baum; Andrew K Burroughs; Diego Vergani; Dimitrios P Bogdanos
Journal:  Clin Rev Allergy Immunol       Date:  2012-04       Impact factor: 8.667

Review 8.  Retroviruses in autoimmune liver disease: genetic or environmental agents?

Authors:  A L Mason; L Xu; L Guo; R F Garry
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1999       Impact factor: 4.291

9.  Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.

Authors:  D P Bogdanos; H Baum; P Butler; E I Rigopoulou; E T Davies; Y Ma; A K Burroughs; D Vergani
Journal:  Dig Liver Dis       Date:  2003-11       Impact factor: 4.088

10.  Lack of association between seroprevalence of Helicobacter pylori infection and primary biliary cirrhosis.

Authors:  Marilena Durazzo; Floriano Rosina; Alberto Premoli; Enrico Morello; Sharmila Fagoonee; Rosaria Innarella; Enrico Solerio; Rinaldo Pellicano; Mario Rizzetto
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

View more
  12 in total

Review 1.  Primary Biliary Cholangitis: Disease Pathogenesis and Implications for Established and Novel Therapeutics.

Authors:  Amitkumar Patel; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2016-10-21

Review 2.  Natural killer T (NKT) cells in autoimmune hepatitis.

Authors:  Jochen Mattner
Journal:  Curr Opin Immunol       Date:  2013-10-19       Impact factor: 7.486

Review 3.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

Review 4.  Cirrhosis and autoimmune liver disease: Current understanding.

Authors:  Rodrigo Liberal; Charlotte R Grant
Journal:  World J Hepatol       Date:  2016-10-08

Review 5.  Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).

Authors:  Jochen Mattner
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

Review 6.  Infection Elicited Autoimmunity and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: An Explanatory Model.

Authors:  Jonas Blomberg; Carl-Gerhard Gottfries; Amal Elfaitouri; Muhammad Rizwan; Anders Rosén
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 7.  The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.

Authors:  Taha Rashid; Clyde Wilson; Alan Ebringer
Journal:  Clin Dev Immunol       Date:  2013-05-27

8.  A Bioinformatics Analysis Reveals Novel Pathogens as Molecular Mimicry Triggers of Systemic Sclerosis.

Authors:  Athanasios Gkoutzourelas; Maria Barmakoudi; Dimitrios P Bogdanos
Journal:  Mediterr J Rheumatol       Date:  2020-03-31

Review 9.  The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?

Authors:  Daniel S Smyk; Athanasios Mavropoulos; Giorgina Mieli-Vergani; Diego Vergani; Marco Lenzi; Dimitrios P Bogdanos
Journal:  Can J Gastroenterol Hepatol       Date:  2018-06-26

10.  Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.

Authors:  Isabell Nilsson; Jeremy Palmer; Eirini Apostolou; Carl-Gerhard Gottfries; Muhammad Rizwan; Charlotte Dahle; Anders Rosén
Journal:  Front Med (Lausanne)       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.